About Enhancer
| Enhancer ID: | E_00968 |
| Species: | Homo sapiens |
| Position : | chr16:164235-164590   |
| Year: | 2025 |
| Title: | An unusual transfusion-dependent hemoglobin H disease caused by a novel complex inverted duplication involving the ??-globin regulatory elements and ??-thalassemia-SEA deletion |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | diffuse large B-cell lymphoma |
| PMID: | 39934429 |
| MONDO: | MONDO:0005042 |
| Tissue: | Lymph node |
| Tissue Ontology ID: | UBERON:0000029 |
| Cell Source: | DHL-4 cells |
| CVCL ID: | CVCL_1886 |
| Cell Type: | diffuse large B-cell lymphoma cell |
| Cell Ontology ID: | CL:0000945 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | ATAC-seq |
| Low Throughput Method: | Luciferase Reporter Assay |
About Target Gene
| Target gene : | HBA1 |
About TF
| TF name : |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Overlapping Enhancers (hg19)
No overlapping enhancers found in hg19 at this locus.
Expression of Target Genes for the Enhancer